GOLDMAN SACHS GROUP INC - COHERUS BIOSCIENCES INC ownership

COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 163 filers reported holding COHERUS BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 1.41 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of COHERUS BIOSCIENCES INC
ValueSharesWeighting
Q2 2024$3,736,853
-8.8%
2,160,031
+26.0%
0.00%0.0%
Q1 2024$4,097,832
+46.9%
1,714,574
+104.7%
0.00%0.0%
Q4 2023$2,789,125
-43.6%
837,575
-36.6%
0.00%0.0%
Q3 2023$4,943,386
+120.7%
1,321,761
+152.0%
0.00%
Q2 2023$2,239,875
-51.6%
524,561
-22.5%
0.00%
-100.0%
Q1 2023$4,630,885
-16.7%
677,030
-3.5%
0.00%0.0%
Q4 2022$5,556,609
+74776.8%
701,592
-9.1%
0.00%
-50.0%
Q3 2022$7,421
+70.6%
772,222
+28.5%
0.00%
+100.0%
Q2 2022$4,351
-99.9%
600,975
+26.6%
0.00%0.0%
Q1 2022$6,128,000
-31.8%
474,659
-15.7%
0.00%
-50.0%
Q4 2021$8,990,000
-14.3%
563,236
-13.7%
0.00%0.0%
Q3 2021$10,485,000
+31.6%
652,486
+13.3%
0.00%0.0%
Q2 2021$7,966,000
-59.1%
575,985
-56.8%
0.00%
-60.0%
Q1 2021$19,492,000
-21.5%
1,334,203
-6.6%
0.01%
-16.7%
Q4 2020$24,837,000
-7.6%
1,429,077
-2.5%
0.01%
-25.0%
Q3 2020$26,876,000
+16.6%
1,465,464
+13.6%
0.01%
+14.3%
Q2 2020$23,049,000
-9.5%
1,290,542
-17.8%
0.01%
-22.2%
Q1 2020$25,472,000
-0.0%
1,570,369
+11.0%
0.01%
+50.0%
Q4 2019$25,473,000
+27.1%
1,414,789
+43.0%
0.01%0.0%
Q3 2019$20,043,000
+73.9%
989,305
+89.7%
0.01%
+100.0%
Q2 2019$11,526,000
+33.9%
521,539
-17.4%
0.00%0.0%
Q1 2019$8,610,000
+120.9%
631,263
+46.6%
0.00%
+200.0%
Q4 2018$3,898,000
-33.9%
430,726
+20.4%
0.00%
-50.0%
Q3 2018$5,901,000
+63.5%
357,659
+38.7%
0.00%
+100.0%
Q2 2018$3,609,000
-21.1%
257,778
-37.7%
0.00%0.0%
Q1 2018$4,572,000
+53.1%
413,757
+21.9%
0.00%0.0%
Q4 2017$2,987,000
+52.6%
339,480
+131.6%
0.00%
Q3 2017$1,957,000
-3.2%
146,597
+4.0%
0.00%
-100.0%
Q2 2017$2,022,000
-32.2%
140,923
-0.1%
0.00%0.0%
Q1 2017$2,984,000
+155.0%
141,095
+239.6%
0.00%
Q4 2016$1,170,000
+45.9%
41,547
+38.7%
0.00%
Q3 2016$802,000
+328.9%
29,957
+171.1%
0.00%
Q2 2016$187,000
-13.4%
11,050
+8.5%
0.00%
Q1 2016$216,000
+6.9%
10,184
+1.0%
0.00%
Q3 2015$202,000
-71.5%
10,083
-56.6%
0.00%
Q1 2015$710,00023,2210.00%
Other shareholders
COHERUS BIOSCIENCES INC shareholders Q2 2023
NameSharesValueWeighting ↓
CM Management, LLC 1,100,000$1,903,0001.75%
AlphaCentric Advisors LLC 1,000,000$1,730,0001.27%
Tejara Capital Ltd 1,030,386$1,782,5680.65%
Rubric Capital Management LP 10,400,000$17,992,0000.47%
Birchview Capital, LP 270,000$467,1000.43%
TANG CAPITAL MANAGEMENT LLC 1,050,000$1,816,5000.18%
Bridge City Capital, LLC 316,009$546,6960.18%
Kohlberg Kravis Roberts & Co. L.P. 3,036,076$5,252,4130.16%
Tyche Wealth Partners LLC 215,902$373,5100.09%
Pennant Investors, LP 168,100$290,8130.08%
View complete list of COHERUS BIOSCIENCES INC shareholders